The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

ConditionST-segment Elevation Myocardial Infarction (STEMI)

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-70

SponsorUniversitas Diponegoro

About this trial

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI

Disqualifiers

History of heart failure due to any causes

Cardiogenic shock before PPCI

Any infection at the time of presentation

Pregnant woman

Trial population

Patient with ST-segment elevation myocardial infarction who underwent PPCI

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

Anion gap
Diagnostic test
Patient was taken blood examination before PPCI

Treatment groups

80 Participants

are divided into 1 treatment group

Group A: MACE group1 intervention